From Casetext: Smarter Legal Research

Medeva Pharma Suisse A.G. v. Par Pharm. Inc.

United States Court of Appeals for the Federal Circuit
Jan 25, 2012
461 F. App'x 933 (Fed. Cir. 2012)

Opinion

2011-1391

01-25-2012

MEDEVA PHARMA SUISSE A.G., WARNER CHILCOTT PHARMACEUTICALS INC., and WARNER CHILCOTT COMPANY, LLC, Plaintiffs-Appellees, v. PAR PHARMACEUTICAL, INC., and EMET PHARMACEUTICALS, LLC, Defendants-Appellants.


ERRATA


Nonprecedential Opinion

Please make the following changes:

Page 1, change "CHRISTOPHER N. SIPES, Covington & Burling, LLP, of Washington, DC, argued for plaintiffs-appellees. With him on the brief were GEORGE F. PAPPAS GARY M. RUBMAN, PAUL A. AINSWORTH, ROGER A. FORD and BRIANNE BHARKHDA.


Summaries of

Medeva Pharma Suisse A.G. v. Par Pharm. Inc.

United States Court of Appeals for the Federal Circuit
Jan 25, 2012
461 F. App'x 933 (Fed. Cir. 2012)
Case details for

Medeva Pharma Suisse A.G. v. Par Pharm. Inc.

Case Details

Full title:MEDEVA PHARMA SUISSE A.G., WARNER CHILCOTT PHARMACEUTICALS INC., and…

Court:United States Court of Appeals for the Federal Circuit

Date published: Jan 25, 2012

Citations

461 F. App'x 933 (Fed. Cir. 2012)

Citing Cases

Eisai R&D Mgmt. v. Dr. Reddy's Labs.

In Medeva, the plaintiff asserted a factual attack, pursuant to Rule 12(b)(1), on a counterclaim premised on…